LYVE1 and hematoma: Liu et al. (2020) observed that subdural hematoma clearance involves drainage into dcLNs via MLVs. Subsequent to subdural hematoma formation, the development and functionality of MLVs are compromised, resulting in a reduced drainage rate and downregulation of lymphangiogenesis-associated molecular markers such as VEGF-C, LYVE1 and FOXC2. In a study by Chen et al. (2024), the administration of Vitamin D to mice with subdural hematomas significantly decreased hematoma volume while facilitating hematoma drainage to dcLNs via MLVs.